ETH Zurich, Prof. Dr Sabine Werner and the SKINTEGRITY.CH consortium: Symposium on the tumour microenvironment

The tumour microenvironment (TME) refers to the complex ecosystem surrounding cancer cells, comprising immune cells, fibroblasts, nerve cells, blood vessels, signalling molecules and the extracellular matrix. Interactions within this environment play a critical role in tumour growth, progression and response to treatment. For instance, cancer-associated fibroblasts and immune cells can either suppress or promote tumour development depending on their activation state.

Understanding the TME is essential for developing more effective cancer treatments. By targeting not only the tumour cells but also their supporting environment, researchers aim to disrupt tumour-promoting signals and enhance anti-tumour immunity, ultimately improving patient outcomes.

Since 1975, the Wilhelm Sander Foundation has supported medical research, particularly in the field of cancer research. To mark the foundation’s 50th anniversary, it has joined forces with the SKINTEGRITY.CH consortium to organise an event that shines a spotlight on some of the cutting-edge research into the tumour microenvironment.

It is therefore with great pleasure that we announce a one-afternoon mini-symposium on Friday, 6 February 2026, at which some of the leading researchers in this field will share their latest findings. The detailed programme for the afternoon is set out below. The event will take place in the “H33 Auditorium” on the Hönggerberg Campus of ETH Zurich (HPM Building, H Floor), at Otto-Stern-Weg 3.

Please note: Registration will open in December 2025.